---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-21-000092"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2021-11-19T23:59:59+00:00"
generated_at: "2026-06-28T06:31:24.986325+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# BioRestorative reduces authorized shares to 75M after 1-for-4,000 reverse split

## Summary
- Board approved reduction of authorized common shares from 300B to 75M, consistent with the 1-for-4,000 reverse split ratio.
- Certificate of Amendment filed with Delaware Secretary of State on November 16, 2021; effective immediately.
- Reverse split was previously effected on October 27, 2021.

## SEC filing metadata
- accession: 0001021771-21-000092
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2021-11-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177121000092/0001021771-21-000092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177121000092/form8kdtd111621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-21-000092
- JSON: https://secwatch.observer/filing/0001021771-21-000092.json
- Plain text: https://secwatch.observer/filing/0001021771-21-000092.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.